Foresite Capital Management III as of March 31, 2018
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 24 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 23.1 | $106M | 2.0M | 54.25 | |
| Arcus Biosciences Incorporated (RCUS) | 9.2 | $42M | 3.4M | 12.21 | |
| Immunomedics | 8.6 | $39M | 2.7M | 14.61 | |
| Alder Biopharmaceuticals | 8.1 | $37M | 2.9M | 12.70 | |
| Achaogen | 8.0 | $37M | 2.9M | 12.95 | |
| Blueprint Medicines (BPMC) | 8.0 | $37M | 400k | 91.70 | |
| Aimmune Therapeutics | 6.5 | $30M | 935k | 31.83 | |
| Cymabay Therapeutics | 4.4 | $20M | 1.6M | 12.99 | |
| Ascendis Pharma A S (ASND) | 4.3 | $20M | 302k | 65.40 | |
| Myokardia | 4.2 | $19M | 393k | 48.80 | |
| Epizyme | 3.9 | $18M | 998k | 17.75 | |
| Verona Pharma Plc ads (VRNA) | 2.5 | $11M | 565k | 20.00 | |
| Acceleron Pharma | 2.4 | $11M | 279k | 39.10 | |
| Audentes Therapeutics | 2.1 | $9.5M | 315k | 30.05 | |
| Aclaris Therapeutics (ACRS) | 1.2 | $5.5M | 312k | 17.52 | |
| Wave Life Sciences (WVE) | 0.7 | $3.0M | 75k | 40.11 | |
| Sangamo Biosciences (SGMO) | 0.6 | $2.9M | 155k | 19.00 | |
| Biohaven Pharmaceutical Holding | 0.6 | $2.7M | 106k | 25.76 | |
| Achaogen Inc put | 0.6 | $2.6M | 200k | 13.00 | |
| Solid Biosciences | 0.4 | $2.0M | 338k | 5.98 | |
| Tocagen | 0.4 | $1.8M | 149k | 11.85 | |
| Ardelyx (ARDX) | 0.2 | $1.0M | 204k | 5.05 | |
| BioDelivery Sciences International | 0.1 | $338k | 150k | 2.25 | |
| Ra Pharmaceuticals | 0.1 | $266k | 50k | 5.32 |
